141 related articles for article (PubMed ID: 16054933)
1. Effect of rimonabant on weight reduction and cardiovascular risk.
van Oosten B; Killestein J; Polman Ch
Lancet; 2005 Jul 30-Aug 5; 366(9483):368-9; author reply 369-70. PubMed ID: 16054933
[No Abstract] [Full Text] [Related]
2. Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist.
van Oosten BW; Killestein J; Mathus-Vliegen EM; Polman CH
Mult Scler; 2004 Jun; 10(3):330-1. PubMed ID: 15222701
[TBL] [Abstract][Full Text] [Related]
3. Effect of rimonabant on weight reduction and cardiovascular risk.
Hirschel B
Lancet; 2005 Jul 30-Aug 5; 366(9483):369; author reply 369-70. PubMed ID: 16054934
[No Abstract] [Full Text] [Related]
4. Rimonabant: obituary for a wonder drug.
Boekholdt SM; Peters RJ
Lancet; 2010 Aug; 376(9740):489-90. PubMed ID: 20709215
[No Abstract] [Full Text] [Related]
5. New diet drug stirs high hopes. But can the pill, rimonabant, liver up to large expectations?
Heart Advis; 2005 Feb; 8(2):3. PubMed ID: 15806687
[No Abstract] [Full Text] [Related]
6. The cardiometabolic drug rimonabant: after 2 years of RIO-Europe and STRADIVARIUS.
Kintscher U
Eur Heart J; 2008 Jul; 29(14):1709-10. PubMed ID: 18556715
[No Abstract] [Full Text] [Related]
7. Effect of rimonabant on weight reduction and cardiovascular risk.
Esposito K; Giugliano D
Lancet; 2005 Jul 30-Aug 5; 366(9483):367-8; author reply 369-70. PubMed ID: 16054931
[No Abstract] [Full Text] [Related]
8. Rimonabant induces partial seizures in a patient with a history of generalized epilepsy.
Braakman HM; van Oostenbrugge RJ; van Kranen-Mastenbroek VH; de Krom MC
Epilepsia; 2009 Sep; 50(9):2171-2. PubMed ID: 19706063
[No Abstract] [Full Text] [Related]
9. Effect of rimonabant on weight reduction and cardiovascular risk.
Astrup A
Lancet; 2005 Jul 30-Aug 5; 366(9483):368; author reply 369-70. PubMed ID: 16054932
[No Abstract] [Full Text] [Related]
10. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.
Després JP; Golay A; Sjöström L;
N Engl J Med; 2005 Nov; 353(20):2121-34. PubMed ID: 16291982
[TBL] [Abstract][Full Text] [Related]
11. [Rimonabant. Risk of depression has not been finally clarified].
Kreutzkamp B
Med Monatsschr Pharm; 2008 May; 31(5):191-2. PubMed ID: 18552079
[No Abstract] [Full Text] [Related]
12. [Endocannabinoid and endocannabinoid receptor antagonists].
Heinzl S
Med Monatsschr Pharm; 2005 Feb; 28(2):40-3. PubMed ID: 15727333
[No Abstract] [Full Text] [Related]
13. Rimonabant: suicide and depression. Depression and suicidal tendencies are about twice as frequent with rimonabant as with placebo.
Prescrire Int; 2007 Dec; 16(92):250. PubMed ID: 18092422
[No Abstract] [Full Text] [Related]
14. [The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant].
Boekholdt SM; Jukema JW; Peters RJ
Ned Tijdschr Geneeskd; 2007 Nov; 151(47):2615-9. PubMed ID: 18161262
[TBL] [Abstract][Full Text] [Related]
15. Rimonabant, obesity and diabetes.
Prescrire Int; 2007 Jun; 16(89):122. PubMed ID: 17585427
[TBL] [Abstract][Full Text] [Related]
16. [The endocannabinoid system and treatment of obesity].
Aronsen L
Tidsskr Nor Laegeforen; 2008 Feb; 128(5):570-1. PubMed ID: 18311201
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks.
Gadde KM; Allison DB
Circulation; 2006 Aug; 114(9):974-84. PubMed ID: 16940206
[No Abstract] [Full Text] [Related]
18. [Prescription of rimonabant in the early stage of pregnancy?].
Picksak G; Stichtenoth DO
Med Monatsschr Pharm; 2008 Mar; 31(3):107-8. PubMed ID: 18429532
[TBL] [Abstract][Full Text] [Related]
19. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.
Van Gaal LF; Rissanen AM; Scheen AJ; Ziegler O; Rössner S;
Lancet; 2005 Apr 16-22; 365(9468):1389-97. PubMed ID: 15836887
[TBL] [Abstract][Full Text] [Related]
20. Rimonabant in obese patients with type 2 diabetes.
Randall MD; Kendall DA; Bennett AJ; O'Sullivan SE
Lancet; 2007 Feb; 369(9561):555. PubMed ID: 17307094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
